Kata Judit Szanto
Overview
Explore the profile of Kata Judit Szanto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bacsur P, Resal T, Farkas B, Jojart B, Gyuris Z, Jaksa G, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335613
Alterations to intestinal microbiota are assumed to occur in the pathogenesis of inflammatory bowel disease (IBD). This study aims to analyze the association of fecal microbiota composition, body composition, and...
2.
Fabian A, Bor R, Vasas B, Szucs M, Toth T, Bosze Z, et al.
World J Gastrointest Endosc
. 2024 Apr;
16(4):193-205.
PMID: 38680198
Background: Choosing an optimal post-polypectomy management strategy of malignant colorectal polyps is challenging, and evidence regarding a surveillance-only strategy is limited. Aim: To evaluate long-term outcomes after endoscopic removal of...
3.
David A, Szanto K, Fabian A, Resal T, Farkas K, Hallgato E, et al.
Prz Gastroenterol
. 2023 Nov;
18(3):334-343.
PMID: 37937107
Introduction: Inflammatory bowel diseases (Crohn's disease (CD) and ulcerative colitis (UC)) are chronic, immune-mediated diseases with unclear aetiology, characterized by relapsing inflammation of the gastrointestinal tract. These conditions significantly impair...
4.
Jojart B, Resal T, Kata D, Molnar T, Bacsur P, Szabo V, et al.
J Crohns Colitis
. 2023 Sep;
18(3):392-405.
PMID: 37751311
Background And Aims: Crohn's disease [CD] and ulcerative colitis [UC] require lifelong treatment and patient monitoring. Current biomarkers have several limitations; therefore, there is an unmet need to identify novel...
5.
Farkas K, Pigniczki D, Rutka M, Szanto K, Resal T, Bor R, et al.
Therap Adv Gastroenterol
. 2021 May;
14:1756284820988198.
PMID: 33953797
The coronavirus disease 2019 (COVID-19) outbreak emerged in December 2019 in China and rapidly spread worldwide. Inflammatory bowel disease (IBD) patients are likely to be more susceptible to viral infections,...
6.
Szanto K, Balazs T, Schrempf D, Farkas K, Molnar T
Therap Adv Gastroenterol
. 2021 Mar;
14:1756284820986670.
PMID: 33717208
Background: There is a lack of data about demographic and treatment characteristics of adolescent patients with inflammatory bowel disease (IBD). The aim of this retrospective, epidemiological study was to evaluate...
7.
Bor R, Szanto K, Fabian A, Farkas K, Szucs M, Rutka M, et al.
BMC Gastroenterol
. 2021 Mar;
21(1):98.
PMID: 33657994
Background: Health care professionals in endoscopic labs have an elevated risk for COVID-19 infection, therefore, we aimed to determine the effect of current pandemic on the workflow and infection prevention...
8.
Szanto K, Madacsy T, Kata D, Ferenci T, Rutka M, Balint A, et al.
Expert Opin Biol Ther
. 2021 Feb;
21(4):539-548.
PMID: 33583295
Introduction: The relationship between clinical outcomes and serum anti-TNF levels is controversial. The of this study was to perform simultaneous analyses of serum, mucosal, and fecal anti-TNF-α levels. Methods: Consecutive...
9.
Bacsur P, Skribanek S, Milassin A, Farkas K, Bor R, Fabian A, et al.
Orv Hetil
. 2020 Nov;
161(47):1989-1994.
PMID: 33226355
Summary: Introduction: Anti-tumor necrosis factor-alpha (anti-TNFα) treatment is reserved for steroid-dependent or steroid/immunomodulator-refractory inflammatory bowel diseases patients. These agents are effective, however, their long-term safety is still questionable. Objective: We...
10.
Balint A, Farkas K, Mehi O, Kintses B, Vasarhelyi B, Ari E, et al.
Pharmaceuticals (Basel)
. 2020 Oct;
13(11).
PMID: 33126430
Gut microbial composition alters in some special situations, such as in ulcerative colits (UC) after total proctocolectomy and ileal pouch-anal anastomosis (IPAA) surgery. The aim of our study was to...